An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer
Clinical trial NCT02365597 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02365597
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-22
- Primary completion
- 2022-09-15
- Enrollment
- 239
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.